A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...

This weekend, thousands of riders will take to the streets for Pelotonia — the annual bike ride that raises millions of dollars for cancer research right here in Columbus. One of the projects ...

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

A new study from researchers in Spain discovered that triple therapy could entirely eliminate pancreatic cancer in mice.

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer usually caught in late stages.

An experimental treatment method has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus ...

DPTX3186, a first-in-class condensate modulator, targets oncogenic Wnt/β-catenin signaling in gastric cancer, aiming to reduce cancer activity with fewer toxicities. The FDA's orphan drug designation ...

What is being hailed as a 'cancer treatment breakthrough' comes not from a brand-new experimental drug, but from a 40-year-old medicine used to treat worms. Researchers from Johns Hopkins University ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...

Dec 29 (Reuters) - Genmab (GMAB.CO), opens new tab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish drugmaker said on Monday. The ...